MedPath

Exthera Medical Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:3
Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (62.5%)
Phase 2
3 (37.5%)

OSCAR II STUDY - The ONCObind CTC Removal Study

Not Applicable
Not yet recruiting
Conditions
Pancreatic Ductal Adenocarcinoma (mPDAC)
Metastatic Colorectal Carcinoma (mCRC)
First Posted Date
2024-10-23
Last Posted Date
2025-07-08
Lead Sponsor
ExThera Medical Corporation
Target Recruit Count
120
Registration Number
NCT06655142
Locations
🇺🇸

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)

Not Applicable
Not yet recruiting
Conditions
Long COVID
First Posted Date
2024-10-15
Last Posted Date
2025-01-24
Lead Sponsor
ExThera Medical Corporation
Target Recruit Count
100
Registration Number
NCT06637800
Locations
🇲🇽

Hospital Angeles Tijuana, Tijuana, Mexico

OSCAR I STUDY - The ONCObind CTC Removal Study

Not Applicable
Completed
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
First Posted Date
2024-07-01
Last Posted Date
2025-07-02
Lead Sponsor
ExThera Medical Corporation
Target Recruit Count
5
Registration Number
NCT06481397
Locations
🇺🇸

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

Blood Purification for the Treatment of Pathogen Associated Shock

Not Applicable
Recruiting
Conditions
Septic Shock
First Posted Date
2021-08-18
Last Posted Date
2025-02-06
Lead Sponsor
ExThera Medical Corporation
Target Recruit Count
15
Registration Number
NCT05011656
Locations
🇺🇸

George Washington University, Washington, District of Columbia, United States

🇺🇸

Southeast Georgia Health System, Inc., Brunswick, Georgia, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

and more 6 locations

Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis

Not Applicable
Completed
Conditions
Bacterial Infection
Bacteremia
First Posted Date
2016-09-26
Last Posted Date
2019-08-12
Lead Sponsor
ExThera Medical Corporation
Target Recruit Count
15
Registration Number
NCT02914132
Locations
🇩🇪

Klinikum Braunschweig, Braunschweig, Germany

🇩🇪

Universitaetsklinikum-Frankfurt, Frankfurt, Germany

🇩🇪

Medizinische Hochschule-Hannover, Hannöver, Germany

and more 1 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath